These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25526094)

  • 1. Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration.
    Buchheit CL; Angarola BL; Steiner A; Weigel KJ; Schafer ZT
    Cell Death Differ; 2015 Aug; 22(8):1275-86. PubMed ID: 25526094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
    Collins NL; Reginato MJ; Paulus JK; Sgroi DC; Labaer J; Brugge JS
    Mol Cell Biol; 2005 Jun; 25(12):5282-91. PubMed ID: 15923641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
    Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
    J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
    Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ
    Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.
    Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U
    Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
    Boisvert-Adamo K; Aplin AE
    Oncogene; 2008 May; 27(23):3301-12. PubMed ID: 18246127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.
    Reginato MJ; Mills KR; Paulus JK; Lynch DK; Sgroi DC; Debnath J; Muthuswamy SK; Brugge JS
    Nat Cell Biol; 2003 Aug; 5(8):733-40. PubMed ID: 12844146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival.
    Giannoni E; Buricchi F; Grimaldi G; Parri M; Cialdai F; Taddei ML; Raugei G; Ramponi G; Chiarugi P
    Cell Death Differ; 2008 May; 15(5):867-78. PubMed ID: 18259192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
    Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
    J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals.
    Giannoni E; Fiaschi T; Ramponi G; Chiarugi P
    Oncogene; 2009 May; 28(20):2074-86. PubMed ID: 19377510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through Bim-mediated intrinsic apoptosis.
    Drury LJ; Wendt MK; Dwinell MB
    PLoS One; 2010 Sep; 5(9):e12895. PubMed ID: 20877573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
    Lauricella M; Ciraolo A; Carlisi D; Vento R; Tesoriere G
    Biochimie; 2012 Feb; 94(2):287-99. PubMed ID: 21835222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
    Uehara N; Matsuoka Y; Tsubura A
    Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells.
    Iglesias-Serret D; de Frias M; Santidrián AF; Coll-Mulet L; Cosialls AM; Barragán M; Domingo A; Gil J; Pons G
    Leukemia; 2007 Feb; 21(2):281-7. PubMed ID: 17151701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis of detached oral squamous cell carcinoma cells by safingol. Possible role of Bim, focal adhesion kinase and endonuclease G.
    Noda T; Iwai S; Hamada M; Fujita Y; Yura Y
    Apoptosis; 2009 Mar; 14(3):287-97. PubMed ID: 19199036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pokemon silencing leads to Bim-mediated anoikis of human hepatoma cell QGY7703.
    Liu K; Liu F; Zhang N; Liu S; Jiang Y
    Int J Mol Sci; 2012; 13(5):5818-5831. PubMed ID: 22754333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.
    Iwakiri D; Minamitani T; Samanta M
    J Virol; 2013 Jul; 87(14):8227-34. PubMed ID: 23698301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
    Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
    Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells.
    Goldstein NB; Johannes WU; Gadeliya AV; Green MR; Fujita M; Norris DA; Shellman YG
    J Invest Dermatol; 2009 Feb; 129(2):432-7. PubMed ID: 18668139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.